Medicus Pharma Ltd.

Medicus Pharma Ltd. (MDCX) has filed two 8-K reports in the past 90 days, both flagged for delisting notices, indicating potential compliance or listing standard violations. Our detection pipeline identified these filings in April and May 2026, with accompanying notices of officer changes and other material events. The full $49 Report extends analysis back 12 months to map the complete arc of these delisting pressures, quantifies dilution risk from any financing activities tied to compliance efforts, and applies AI risk signals to assess whether this represents a temporary listing administrative matter or a deeper solvency concern. The full $49 Report adds historical context, dilution trajectory, and forward risk scoring to distinguish signal from noise.